Nazatasone Nasal Spray (Mometasone Furoate)

Adult use

Allergic rhinitis: Spray twice in each nostril once daily (total daily dose 0.2 mg). The dosage can be reduced to once in each nostril when symptoms improve (total daily dose 0.1 mg). Up to four sprays in each nostril once daily may be given (total daily dose 0.4 mg). Regular use is recommended. Nasal polyps: Spray twice in each nostril once daily (total daily dose 0.2 mg).

Child use

Allergic rhinitis: Spray once in each nostril once daily (total daily dose 0.1 mg).

This drug is a corticosteroid for nasal use and should not be used in certain patients. It should not be administered to those who have allergies to this medication or its components, or have untreated infections in the nasal mucosa. Additionally, it should not be used in patients who have undergone recent nasal surgery or have nasal wounds, and in infants under 2 years of age. Patients with respiratory infections, tuberculosis, herpes simplex in the eyes, those who frequently have nosebleeds, those at risk of exposure to chickenpox or measles, patients with unilateral nasal polyps or polyps related to cystic fibrosis, and pregnant or breastfeeding women should use this drug with caution. When using this medication, various adverse reactions such as headaches, viral infections, pharyngitis, nosebleeds, cough, and upper respiratory infections may occur. Rarely, bronchospasm or severe allergic reactions may occur, so if symptoms are severe, the use should be stopped immediately and medical attention should be sought. Long-term use at high doses may lead to systemic steroid side effects, so caution is necessary. Additionally, nasal infections or changes in the nasal mucosa may occur, hence regular check-ups are recommended. Using this medication may increase the risk of chickenpox or measles infection, necessitating attention to infection prevention and early diagnosis. It is particularly important to check vaccination status against chickenpox or measles and consult medical personnel immediately if infection is suspected. When administering to children, the minimum dose should be used considering the potential for growth delay, and their growth should be monitored regularly. In elderly patients, it should be administered with caution considering the decline in bodily functions. In case of overdose, no specific treatment is necessary, but caution should be exercised due to potential systemic steroid side effects. Before use, shake the container well, and perform a specified number of test sprays to ensure uniform spraying. Care should be taken not to spray directly into the eyes or the septum. It is safest to store the medication out of reach of children. This medication may interact with other drugs, so caution is needed, especially for those taking CYP3A4 inhibitors, and if other medications are being used, one must consult with a doctor or pharmacist. Pregnant or breastfeeding women should use this medication only under the guidance of a physician, considering its potential impact on the fetus or infant.

Serious side effects

Hives, severe swelling (edema), chest tightness, difficulty breathing, cold sweat, pallor, severe allergic reactions, severe rash with high fever, blisters, skin peeling, pain in mucous membranes of the mouth/eyes, severe skin reactions, feeling breathless or difficulty breathing, asthma attacks, respiratory issues along with cough and fever, respiratory problems, yellowing of the skin or eyes (jaundice), extreme lethargy, liver dysfunction (jaundice), sudden

Mild side effects

Headaches, viral infections, pharyngitis, nosebleeds/blood-stained mucus, cough, upper respiratory infections, menstrual disorders, musculoskeletal pain, sinusitis, vomiting, joint pain, asthma, bronchitis, chest pain, conjunctivitis, diarrhea, indigestion, ear pain, cold symptoms, muscle pain, nausea, rhinitis, diarrhea, nasal inflammation, otitis media, wheezing, skin trauma, nasal symptoms (irritation, itching, dryness, pain, redness, discomfort, etc.), throat symptoms (irritation, pain

This medication should be stored in a tightly sealed container to prevent exposure to air or moisture, ideally at room temperature between 2 and 25 degrees Celsius. Storing it this way helps maintain the medication's effectiveness for a longer period.

Appearance

An opaque suspension that is white or nearly white, contained in a spray bottle with a specified amount.

Package unit

1 bottle (18g/bottle)